Cogent Biosciences, Inc.COGTNASDAQ
Loading
Operating cash flow minus capital expenditures
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-266.00M | -27.7% |
| 2024 | $-208.36M | -33.2% |
| 2023 | $-156.42M | -24.6% |
| 2022 | $-125.50M | -107.5% |
| 2021 | $-60.48M | -68.7% |
| 2020 | $-35.85M | +13.7% |
| 2019 | $-41.55M | -25.8% |
| 2018 | $-33.04M | -23.5% |
| 2017 | $-26.75M | -21.9% |
| 2016 | $-21.95M | - |